Previous close | 100.00 |
Open | 99.72 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 99.34 - 101.54 |
52-week range | 79.50 - 138.90 |
Volume | |
Avg. volume | 4,427 |
Market cap | 111.659M |
Beta (5Y monthly) | 1.09 |
PE ratio (TTM) | 0.16 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Revvity's (RVTY) latest offering is likely to significantly accelerate the pace of drug innovation, with efficient data sharing into one seamless platform.
Revvity (RVTY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Key Insights Significantly high institutional ownership implies Revvity's stock price is sensitive to their trading...